1. Home
  2. BNGO vs ALUR Comparison

BNGO vs ALUR Comparison

Compare BNGO & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.51

Market Cap

24.3M

Sector

Industrials

ML Signal

HOLD

ALUR

Allurion Technologies Inc.

HOLD

Current Price

$1.33

Market Cap

18.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNGO
ALUR
Founded
2003
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
18.9M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
BNGO
ALUR
Price
$1.51
$1.33
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$6.33
$9.25
AVG Volume (30 Days)
192.4K
83.5K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$28,720,000.00
$17,208,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$24.56
$9.02
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.45
$1.02
52 Week High
$22.80
$16.81

Technical Indicators

Market Signals
Indicator
BNGO
ALUR
Relative Strength Index (RSI) 39.71 36.53
Support Level $1.61 $1.29
Resistance Level $1.63 $1.48
Average True Range (ATR) 0.07 0.11
MACD -0.01 -0.02
Stochastic Oscillator 7.52 6.52

Price Performance

Historical Comparison
BNGO
ALUR

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Share on Social Networks: